While eConsent has become more widely adopted since COVID-19, work still needs to be done in improving patients’ understanding.
Kate Godwin-Smith
Advertisement
Director, Client Services, Patient Consent Solutions, IQVIA Technologies
Articles by Kate Godwin-Smith
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Beyond Patient Centricity: What Rare Disease Research Gets Right
2
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
3
ACT Brief: Hidden RBQM Value, Rare Disease Patient Partnership, and Safety Perception in IBD
4
The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness
5